Epidemiology and Burden of Alopecia Areata: A Systematic Review

    July 2015 in “ Clinical, Cosmetic and Investigational Dermatology ”
    Alexandra C. Villasante Fricke, Mariya Miteva
    Image of study
    TLDR Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.
    The 2015 systematic review found that alopecia areata (AA) is a common autoimmune disorder with a global lifetime incidence of about 2%, affecting individuals with no significant sex predominance, typically beginning in the third and fourth decades of life. An earlier onset is linked to a greater risk of severe disease. The global burden of AA was significant, with 1,332,800 disability-adjusted life years (DALYS) calculated in 2010. AA patients often suffer from psychiatric comorbidities like depression and anxiety, as well as other autoimmune diseases such as atopy, vitiligo, and thyroid disease. Stressful events were recalled by 9.8% of adults and 9.5%-80% of children with AA before hair loss onset. Certain age groups had a higher risk of psychiatric issues, with under 20s more prone to depression and 40-59 year-olds to anxiety and obsessive-compulsive disorder. The incidence of atopy in AA patients was between 11% and 38.2%, and 5% had subclinical hypothyroidism. AA was also linked to other autoimmune disorders, and genetic studies have identified genes related to inflammation and immune modulation. The review emphasized the need for standardized international research to better understand AA epidemiology.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 1000+ results

      community AGA evaluation and first steps - BEGINNER MEGAPOST

      in Chat  76 upvotes 3 months ago
      The conversation discusses androgenic alopecia (AGA) and its treatments, focusing on finasteride, minoxidil, and ketoconazole shampoo. Finasteride is recommended as essential for preventing further hair loss.

      community 17M biotin and minoxidil hair regrowth progress

      in Progress Pictures  83 upvotes 1 year ago
      A user's hair regrowth journey using biotin and minoxidil after initial treatments with Nizoral shampoo and Ketoconazole serum didn't work. The comments suggest the hair loss might not be male pattern baldness (MPB), but possibly Alopecia Areata, an autoimmune disorder, and recommend getting a second opinion and considering other treatments like corticosteroids.

      community To anyone that is still not seeing results on the big 3…

      in Treatment  106 upvotes 2 years ago
      User redh0t12 suggests using a derma pen for hair regrowth, as it helped them after using finasteride and minoxidil. Others discuss their experiences with various treatments, including derma rolling, oral and topical minoxidil, and finasteride, with mixed results.

      community When are we getting a cure to hair loss?

      in Chat 1 year ago
      Potential treatments for hair loss, including Minoxidil, finasteride, RU58841 and various upcoming pharmaceuticals, gene editing and cloning. It is suggested that a cure, if found, would be highly profitable due to the large number of people affected by hair loss globally.

      community any news about DUPA (Diffuse unpatterned alopecia)?

      in Research/Science  9 upvotes 2 years ago
      The conversation discusses diffuse unpatterned alopecia (DUPA) and its possible causes, including sensitivity to DHT, not being androgenic alopecia, being diffuse alopecia areata, or hormonal issues. Treatments mentioned include topical melatonin, Clobetasol Propionate for alopecia areata, and the lack of results from using finasteride, dutasteride, and minoxidil.

    Related Research

    3 / 3 results